Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Pulmonary aspergillosis: a clinical review

M. Kousha, R. Tadi, A.O. Soubani
European Respiratory Review 2011 20: 156-174; DOI: 10.1183/09059180.00001011
M. Kousha
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Tadi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.O. Soubani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: asoubani@med.wayne.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    The spectrum of pulmonary aspergillosis.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    a) Chest computed tomography image showing left upper lobe cavitary lesion consistent with invasive pulmonary aspergillosis (IPA) in an allogeneic haematopoietic stem-cell transplantation recipient. b) Brain magnetic resonance image from the same patient showing left parietal ring enhancing lesion due to disseminated IPA.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Invasive pulmonary aspergillosis. a) Pulmonary parenchyma with necrosis and pulmonary haemorrhage and Aspergillus hyphae (haematoxylin and eosin 100×). b) Branching Aspergillus hyphae involving lung parenchyma (Grocott Methenamine silver fungus stain 200×). Images courtesy of Dr. Mousa Al-Abbadi (East Tennessee State University, Johnson City, TN, USA).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Chest computed tomography image showing a right upper lobe aspergilloma in a patient with sarcoidosis.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Chest computed tomography image showing central bronchiectasis in a patient with allergic bronchopulmonary aspergillosis.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Clinical scenarios of Aspergillus overlap syndromes in the lungs. ABPA: allergic bronchopulmonary aspergillosis; IPA: invasive pulmonary aspergillosis; CNA: chronic necrotising aspergillosis.

Tables

  • Figures
  • Table 1. Classical risk factors for invasive pulmonary aspergillosis
    Prolonged neutropenia (<500 cells·mm−3 for >10 days) [10]
    Transplantation (highest risk is with lung transplantation and HSCT) [11–14]
    Prolonged (>3 weeks) and high-dose corticosteroid therapy [10, 15, 16]
    Haematological malignancy (risk is higher with leukaemia) [5, 7]
    Chemotherapy [5, 7, 17]
    Advanced AIDS [18–21]
    Chronic granulomatous disease [22]
    • HSCT: haematopoietic stem-cell transplantation.

  • Table 2. Diagnostic criteria for invasive pulmonary aspergillosis
    DiagnosisCriteria
    ProvenHistopathological or cytopathological examination of lung tissue showing hyphae from needle aspiration or biopsy specimen with evidence of associated tissue damage
    OR
    positive culture result for Aspergillus from a sample obtained by sterile procedure from the lung
    AND
    clinically or radiologically abnormal site consistent with infection
    ProbableHost factor (table 1)
    AND
    mycological evidence (positive Aspergillus microscopy or culture from the sputum or BAL or positive antigen assay#)
    AND
    clinical criteria consistent with infection¶
    PossibleHost factor (table 1)
    AND
    clinical criteria consistent with the infection¶
    • BAL: bronchoalveolarlavage. #: Positive antigen assay: galactomannan antigen detected in plasma, serum, BAL fluid or cerebrospinal fluid, or β-d-glucan detected in serum. ¶: Clinical criteria: new characteristic infiltrates on computed tomography imaging (dense, well-circumscribed lesion(s) with or without a halo sign, air-crescent sign, or cavity), tracheobronchitis seen by bronchoscopy, or noncharacteristic new infiltrates with a specific pulmonary symptom or sign (such as pleural rub, pleural pain, haemoptysis). Adapted from [117].

  • Table 3. Treatment recommendations for pulmonary aspergillosis
    DiseasePrimary treatmentOther treatments
    Invasive pulmonary aspergillosisVoriconazole [119–123]Alternative therapy: liposomal amphotericin B [124]
    Continuation therapy: voriconazole or itraconazole [122, 123]
    Salvage therapy: echinocandin or posaconazole [125–127]
    Chronic necrotising aspergillosisVoriconazole [120, 123]Alternative therapy: itraconazole [128, 129]
    Severe cases: intravenous voriconazole or liposomal amphotericin B [123, 128, 130]
    Consider surgical resection [130]
    AspergillomaObservation [123]Bronchial artery embolisation [131]
    Surgical resection [132–135]
    Consider itraconazole [136–138]
    Allergic bronchopulmonary aspergillosisCorticosteroids [139–142]Itraconazole or voriconazole as steroid-sparing agents [143–146]
  • Table 4. Diagnostic criteria for chronic necrotising aspergillosis
    Diagnostic criteriaCharacteristics
    ClinicalChronic (>1 month) pulmonary or systemic symptoms, including at least one of: weight loss, productive cough or haemoptysis
    No overt immunocompromising conditions (e.g. haematological malignancy, neutropenia, organ transplantation)
    RadiologicalCavitary pulmonary lesion with evidence of paracavitary infiltrate
    New cavity formation, or expansion of cavity size over time
    LaboratoryElevated levels of inflammatory markers (C-reactive protein, plasma viscosity or erythrocyte sedimentation rate). Isolation of Aspergillus spp. from pulmonary or pleural cavity, or positive serum Aspergillus precipitin test. Exclusion of other pulmonary pathogens, by results of appropriate cultures and serological tests, that are associated with similar disease presentation, including mycobacteria and endemic fungi
    • Adapted from [186].

  • Table 5. Diagnostic criteria for allergic bronchopulmonary aspergillosis
    Asthma
    Immediate skin reactivity to Aspergillus
    Serum precipitins to Aspergillus fumigatus
    Increased serum IgE and IgG to Aspergillus fumigatus
    Total serum IgE >1000 IU·mL−1
    Current or previous pulmonary infiltrates
    Central bronchiectasis
    Peripheral eosinophilia (1000 cells·μL−1)
    • lg: immunoglobulin. Adapted from [231, 233].

PreviousNext
Back to top
View this article with LENS
Vol 20 Issue 121 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pulmonary aspergillosis: a clinical review
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Pulmonary aspergillosis: a clinical review
M. Kousha, R. Tadi, A.O. Soubani
European Respiratory Review Sep 2011, 20 (121) 156-174; DOI: 10.1183/09059180.00001011

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Pulmonary aspergillosis: a clinical review
M. Kousha, R. Tadi, A.O. Soubani
European Respiratory Review Sep 2011, 20 (121) 156-174; DOI: 10.1183/09059180.00001011
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • INVASIVE PULMONARY ASPERGILLOSIS
    • CHRONIC NECROTISING ASPERGILLOSIS
    • ASPERGILLOMA
    • ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
    • PULMONARY ASPERGILLUS OVERLAP SYNDROMES
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Role of air pollutants in airway epithelial barrier dysfunction
  • E-cigarettes and nicotine abstinence
  • Lung imaging in cystic fibrosis
Show more Review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2023 by the European Respiratory Society